Caresyntax, a Boston, MA-based enterprise-level digital surgery platform delivering actionable insights to improve surgery, closed a $100m Series C funding.
The round was led by PFM Health Sciences LP, and included participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, as well as current investors IPF Partners, the Relyens Group, and Surgical.
The company intends to use the funds to accelerate expansion in key markets, further research and development of its AI analytics, build out its platforms, and expand its employee base.
Led by Dennis Kogan, founder and CEO, Caresyntax provides an enterprise-grade digital surgery platform that delivers actionable insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. This real world evidence can be used by the care team live, during a procedure and accessed by those outside the operating room via the platform’s dedicated telehealth link. After a procedure, the platform provides insights for surgeons to benchmark and improve their care, for hospital administrators to use surgical resources more efficiently, for medical device companies to advance products, and for insurance companies to understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide and supports surgical teams in over two million procedures per year.
At the close of 2019, Caresyntax announced the acquisition of Syus, a leader in operating room operations and cost analytics. This acquisition extended Caresyntax’s hospital footprint and further enhanced the company’s capabilities to improve business outcomes for hospitals via real-world data.